Related Experiment Video
Updated: Aug 2, 2026
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
Management of patients receiving transperineal palladium-103 prostate implants
1Department of Radiation Oncology, University Community Hospital, Tampa, FL, USA.
Purpose/Objectives:
To describe the complexities of the medical management of patients undergoing treatment of prostate cancer; discuss the sequelae of treatment options, including surgery, external beam radiation, and brachytherapy; outline the evolution of interstitial prostatic brachytherapy and the current use of transperineal ultrasound-guided prostate implants using palladium-103 (103Pd), and discuss the side effects of the 103Pd prostate implant as well as the nursing management of patients who receive the implants.
Data Sources:
Published articles and State of Florida administrative codes.
Data Synthesis:
Transperineal 103Pd implants are a viable and contemporary treatment for early stage prostate cancer that provide the advantages of an outpatient procedure along with less acute morbidity and better potency preservation.
Conclusions:
Side effects associated with 103Pd implants are predictable, short-lived, and easily managed. Sexual function is maintained in most men. Patient education greatly reduces patient anxiety.
Implications For Nursing Practice:
Nurses' roles include preprocedure assessment, intraprocedure care and postimplant monitoring, and patient education for discharge.
